Single Dose of Pharmaceutical LSD Shows Promise in Relieving Anxiety for Months
AI-Generated Summary
A preliminary study on MM120, an oral form of pharmaceutical LSD, suggests a single dose could significantly relieve symptoms of generalized anxiety disorder (GAD) for up to three months. Conducted by MindMed on 198 adults, the study found nearly two-thirds of participants experienced improved anxiety symptoms 12 weeks later, compared to a placebo. This research offers a potential long-lasting alternative to current GAD treatments, which often have limitations.
In a nutshell
This study is significant as the first modern trial examining LSD specifically for GAD, a condition where traditional treatments like SSRIs often fail or have unwanted side effects. The potential for a single dose to provide months of relief represents a substantial shift from daily medication regimens, offering a new avenue for mental health treatment.
Source: UPI News
